A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA

Completed · Not applicable

Conditions studied: Healthy Volunteer

In brief

This study will evaluate the specificity of the cobas TaqScreen MPX Test for the simultaneous detection of HBV DNA, HCV RNA and HIV-1 Group M in a minimum of 100,000 individual donor samples in 96-unit pools.

Key facts

Study ID

NCT00520273

Run by

Hoffmann-La Roche

People needed

100000

Starts

2007-08-01

Expected to finish

2007-10-01

Last updated by the study team

2016-03-02

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adults 18-65 years of age
• Fulfil criteria for plasma donation

You may not qualify if…

• Do not fulfil criteria for plasma donation

Where it is running

• Study site — Boca Raton, Florida, United States
• Study site — Raleigh, North Carolina, United States
• Study site — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.